Unknown NA INTERVENTIONAL 2-arm NCT03230825

Oral Contraceptive Pills Versus Expectant Management for Retained Pregnancy Products

Oral Contraceptive Pills Versus Expectant Management for Retained Pregnancy Products After a First Trimester Miscarriage: a Randomized Clinical Trial

Sponsor: Meir Medical Center

Conditions Retained Products of Conception Post Abortion

Interventions Expectant management Oral contraceptive

Updated 6 times since 2017 Last updated: Aug 6, 2017 Started: Sep 30, 2017 Primary completion: Sep 30, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03230825, this NA trial focuses on Retained Products of Conception Post Abortion and remains ongoing. Sponsored by Meir Medical Center, it has been updated 6 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Sep 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Sep 2019 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Aug 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Meir Medical Center

Data source: Meir Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.